BNP Paribas Financial Markets Has $445,000 Holdings in American Healthcare REIT, Inc. (NYSE:AHR)

BNP Paribas Financial Markets cut its stake in American Healthcare REIT, Inc. (NYSE:AHR) by 95.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,035 shares of the company’s stock after selling 355,238 shares during the period. BNP Paribas Financial Markets’ holdings in American Healthcare REIT were worth $445,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Kozak & Associates Inc. bought a new stake in American Healthcare REIT during the 3rd quarter worth approximately $28,000. Tidemark LLC bought a new stake in American Healthcare REIT during the 3rd quarter worth approximately $44,000. Kessler Investment Group LLC bought a new stake in American Healthcare REIT during the 3rd quarter worth approximately $48,000. KBC Group NV bought a new stake in American Healthcare REIT during the 3rd quarter worth approximately $51,000. Finally, Kiely Wealth Advisory Group Inc. bought a new stake in American Healthcare REIT during the 2nd quarter worth approximately $30,000. 16.68% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on AHR shares. JMP Securities increased their price target on American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th. Morgan Stanley increased their price objective on American Healthcare REIT from $17.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 22nd. Bank of America increased their price objective on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Tuesday, September 24th. KeyCorp increased their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, September 16th. Finally, Colliers Securities upgraded American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $25.13.

American Healthcare REIT Stock Up 0.5 %

NYSE:AHR opened at $28.47 on Friday. American Healthcare REIT, Inc. has a 12-month low of $12.63 and a 12-month high of $29.99. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. The firm has a market capitalization of $4.36 billion and a P/E ratio of -59.31. The stock’s fifty day simple moving average is $26.83 and its 200-day simple moving average is $21.42.

American Healthcare REIT (NYSE:AHR) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.35). American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. The company had revenue of $523.81 million during the quarter, compared to the consensus estimate of $474.26 million. The business’s quarterly revenue was up 12.8% on a year-over-year basis. Equities research analysts expect that American Healthcare REIT, Inc. will post 1.42 earnings per share for the current year.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.